Inclusive
7078
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
Land
8918
(Q1)Aug 20, 2024 | (FY)May 20, 2024 | (Q4)May 20, 2024 | (Q3)Feb 20, 2024 | (Q2)Nov 20, 2023 | (Q1)Aug 20, 2023 | (FY)May 20, 2023 | (Q4)May 20, 2023 | (Q3)Feb 20, 2023 | (Q2)Nov 20, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 4.70%118.38B | 5.59%471.68B | 8.12%121.62B | 4.21%118.78B | 7.31%118.21B | 2.71%113.07B | 4.25%446.71B | 1.78%112.49B | 4.60%113.97B | 3.35%110.16B |
Cost of revenue | 6.04%90.41B | 4.27%354.18B | 6.46%91.31B | 2.28%89.21B | 6.19%88.4B | 2.19%85.25B | 5.02%339.67B | 3.47%85.78B | 5.81%87.22B | 3.21%83.25B |
Gross profit | 0.56%27.98B | 9.77%117.5B | 13.45%30.31B | 10.50%29.57B | 10.78%29.81B | 4.35%27.82B | 1.87%107.04B | -3.29%26.71B | 0.86%26.76B | 3.78%26.91B |
Operating expense | 1.64%25.4B | 8.80%100.55B | 15.10%25.85B | 5.09%24.32B | 9.83%25.4B | 5.43%24.99B | 1.83%92.42B | -6.24%22.46B | 2.45%23.14B | 2.73%23.12B |
Operating profit | -8.95%2.58B | 15.96%16.95B | 4.74%4.46B | 45.15%5.25B | 16.52%4.42B | -4.33%2.83B | 2.17%14.62B | 15.99%4.26B | -8.24%3.62B | 10.69%3.79B |
Net non-operating interest income (expenses) | 14.74%-81M | -38.58%-352M | 1.16%-85M | -18.06%-85M | -85.11%-87M | -93.88%-95M | -38.80%-254M | -86.96%-86M | -50.00%-72M | -9.30%-47M |
Non-operating interest income | 88.89%17M | -9.09%40M | -26.67%11M | 11.11%10M | -9.09%10M | 0.00%9M | 2.33%44M | 25.00%15M | -10.00%9M | 0.00%11M |
Non-operating interest expense | -5.77%98M | 31.54%392M | -4.95%96M | 17.28%95M | 67.24%97M | 79.31%104M | 31.86%298M | 74.14%101M | 39.66%81M | 7.41%58M |
Net investment income | 166.67%16M | -50.00%6M | ||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -50M | 0 | 0 | 0 | 0 | 0 | 155.00%22M | 0 | 0 | 0 |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 66.67%-6M | 587,850.00%11.76B | 182.46%94M | 146,175.00%11.69B | -105.15%-7M | -12.50%-18M | 99.44%-2M | 74.38%-114M | 91.84%-8M | -28.80%136M |
Less:Other special charges | -66.67%6M | -34,511.76%-11.77B | -237.18%-107M | -146,175.00%-11.69B | 105.15%7M | 12.50%18M | -110.43%-34M | -81.11%78M | -91.84%8M | 28.80%-136M |
Less:Write off | ---- | -63.89%13M | ---- | ---- | ---- | ---- | 12.50%36M | ---- | ---- | ---- |
Other non-operating income (expenses) | -4.94%77M | 116.67%13M | 40.00%21M | 55.88%53M | -138.46%-10M | -43.36%81M | -68.42%6M | 0.00%15M | -64.21%34M | |
Income before tax | -9.41%2.45B | 96.52%28.43B | 10.26%4.48B | 374.87%16.87B | 12.08%4.37B | -8.23%2.71B | 4.30%14.47B | 27.01%4.06B | -6.79%3.55B | 6.33%3.9B |
Income tax | -9.26%823M | 98.47%8.96B | 9.88%1.41B | 478.28%5.25B | 8.91%1.39B | -12.96%907M | -1.36%4.51B | 17.57%1.29B | -25.29%907M | 2.57%1.28B |
Net income | -9.44%1.63B | 95.65%19.47B | 10.44%3.07B | 339.42%11.63B | 13.63%2.98B | -5.66%1.8B | 7.08%9.95B | 31.91%2.78B | 1.89%2.65B | 8.22%2.62B |
Net income continuous operations | -9.49%1.63B | 95.64%19.47B | 10.44%3.07B | 339.42%11.63B | 13.63%2.98B | -5.65%1.8B | 7.08%9.95B | 31.91%2.78B | 1.85%2.65B | 8.26%2.62B |
Noncontrolling interests | 19.44%86M | 101.20%334M | -10.59%76M | 254.55%117M | 130.00%69M | 300.00%72M | 86.52%166M | 174.19%85M | 153.85%33M | 11.11%30M |
Net income attributable to the company | -10.70%1.54B | 95.56%19.14B | 11.10%2.99B | 340.62%11.51B | 12.28%2.91B | -8.57%1.73B | 6.31%9.79B | 29.83%2.69B | 1.04%2.61B | 8.23%2.59B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -10.70%1.54B | 95.56%19.14B | 11.10%2.99B | 340.62%11.51B | 12.28%2.91B | -8.57%1.73B | 6.31%9.79B | 29.83%2.69B | 1.04%2.61B | 8.23%2.59B |
Gross dividend payment | ||||||||||
Basic earnings per share | -9.36%16.08 | 95.63%196.47 | 11.61%30.85 | 340.45%118.04 | 12.26%29.84 | -8.60%17.74 | 10.57%100.43 | 30.93%27.64 | 5.72%26.8 | 13.78%26.58 |
Diluted earnings per share | -9.32%16.05 | 95.66%196.36 | 11.59%30.82 | 340.37%118.02 | 12.36%29.82 | -8.72%17.7 | 10.57%100.36 | 30.84%27.62 | 5.76%26.8 | 13.81%26.54 |
Dividend per share | 0 | 5.88%36 | 0.00%18 | 0 | 12.50%18 | 0 | 9.68%34 | 12.50%18 | 0 | 6.67%16 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |